MarketScreener Homepage > Equities > NASDAQ OMX STOCKHOLM > C-Rad AB (publ) CRAD B SE0002016352

Report

Delayed NASDAQ OMX STOCKHOLM - 01/21 11:29:56 am
47.15	SEK		+0.96%

01/18

C RAD : Web Presentation Year-end Report 2020

2020

C RAD : receives order for proton cancer treatment centers in the US

2020

C RAD : Shenzhen proton therapy treatment center selects C-RAD Catalyst™ system

Summary

Quotes 5-day view Delayed Quote.

Delayed Nasdaq Omx Stockholm

01/15/2021	01/18/2021	01/19/2021	01/20/2021	01/21/2021	Date
46.6(c)	46.5(c)	45.5(c)	46.7(c)	47.15	Last
23 169	11 818	23 827	15 467	21 098	Volume
-0.96%	-0.21%	-2.15%	+2.64%	+0.96%	Change

More quotes

Financials

Sales 2018	190 M 23,0 M 23,0 M
Net income 2018	21,2 M 2,56 M 2,56 M
Net cash position 2018	9,33 M 1,13 M 1,13 M
P/E ratio 2018	37,9x
Yield 2018	-

Sales 2019	205 M 24,8 M 24,8 M
Net income 2019	-13,8 M -1,67 M -1,67 M
Net cash position 2019	6,83 M 0,82 M 0,82 M
P/E ratio 2019	-98,9x
Yield 2019	-

Capitalization	1 572 M 188 M 190 M
EV / Sales 2018	4,12x
EV / Sales 2019	6,69x
Nbr of Employees	56
Free-Float	66,7%

More Financials

Company

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the...

Sector

Advanced Medical Equipment & Technology

Calendar

01/28

Ergebnisveröffentlichung

More about the company

All news about C-RAD AB (PUBL)

01/18	C RAD : Web Presentation Year-end Report 2020	AQ
2020	C RAD : receives order for proton cancer treatment centers in the US	AQ
2020	C RAD : Shenzhen proton therapy treatment center selects C-RAD Catalyst™ s..	AQ
2020	C RAD : 15 percent growth in order intake and record high operating profit	AQ
2020	C RAD : Web Presentation Interim Report Q3 2020	AQ
2020	C RAD : Australian customers select C-RAD's cutting edge SIGRT solution	AQ
2020	C RAD : Shanghai Proton and Heavy Ion Hospital decides for C-RAD SIGRT solution	AQ
2020	C RAD : and Elekta expand cooperation - Elekta to distribute C-RAD's cutting-edg..	AQ
2020	C RAD PUBL : Positive operating income in challenging times	AQ
2020	C RAD PUBL : RAD Web Presentation Half-Year Report 2020	AQ
2020	C RAD PUBL : DTZ Berlin selects C-RAD's cutting-edge SIGRT solution	AQ
2020	C RAD PUBL : RAD is seleted to equip the Shenzhen proton therapy treatment enter..	AQ
2020	C RAD PUBL : Former employee has filed a lawsuit for compensation	AQ
2020	C RAD PUBL : RAD AB - Interim report January - Marh 2020	AQ
2020	C RAD PUBL : RAD Web Presentation Interim Report Q1 2020	AQ

More news

News in other languages on C-RAD AB (PUBL)

- No features available -

More news

Provided by Scoopnest.com

Chart C-RAD AB (PUBL)

Duration : Period :

C-Rad AB (publ) Technical Analysis Chart | CRAD B | SE0002016352 | MarketScreener

Full-screen chart

Technical analysis trends C-RAD AB (PUBL)

	Short Term	Mid-Term	Long Term
Trends	Bullish	Bullish	Bullish

Technical analysis

Income Statement Evolution

More Financials

Managers and Directors

Name	Title
Tim Thurn	President & Chief Executive Officer
Lars Gunnar Nyberg	Chairman
Hakan Axelsson	Chief Operating Officer
Henrik Bergentoft	Chief Financial Officer
Peter Hamberg	Independent Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

C-RAD AB (PUBL)	-3.11%	188



THERMO FISHER SCIENTIFIC	8.93%	204 446
DANAHER CORPORATION	6.71%	168 395
INTUITIVE SURGICAL, INC.	-2.39%	93 876
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	7.26%	83 588
ILLUMINA, INC.	9.06%	58 917

More Results